147 related articles for article (PubMed ID: 12069197)
1. Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma.
Fujiwara H; Shibahara H; Usui R; Takamizawa S; Kosuge S; Ohwada M; Suzuki M; Sato I
Am J Reprod Immunol; 2002 Mar; 47(3):129-31. PubMed ID: 12069197
[No Abstract] [Full Text] [Related]
2. Primary hormonal treatment for early endometrial carcinoma.
Sardi J; Anchezar Henry JP; Paniceres G; Gomez Rueda N; Vighi S
Eur J Gynaecol Oncol; 1998; 19(6):565-8. PubMed ID: 10215442
[TBL] [Abstract][Full Text] [Related]
3. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
[TBL] [Abstract][Full Text] [Related]
4. Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?
Vinker S; Shani A; Open M; Fenig E; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):63-5. PubMed ID: 10221612
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
Mao Y; Wan X; Chen Y; Lv W; Xie X
Fertil Steril; 2010 Jan; 93(1):283-5. PubMed ID: 19962142
[TBL] [Abstract][Full Text] [Related]
6. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations.
Imai M; Jobo T; Sato R; Kawaguchi M; Kuramoto H
Eur J Gynaecol Oncol; 2001; 22(3):217-20. PubMed ID: 11501776
[TBL] [Abstract][Full Text] [Related]
7. [Hormonal therapy in the treatment of endometrial adenocarcinoma].
Rob L
Ceska Gynekol; 1996 Aug; 61(4):249-50. PubMed ID: 8963496
[No Abstract] [Full Text] [Related]
8. Multicystic pulmonary metastases of endometrial carcinoma.
Beuselinck B; Weytjens K; Vanbockrijk M; Mebis J
Acta Clin Belg; 2005; 60(5):257-9. PubMed ID: 16398324
[No Abstract] [Full Text] [Related]
9. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger.
Ota T; Yoshida M; Kimura M; Kinoshita K
Int J Gynecol Cancer; 2005; 15(4):657-62. PubMed ID: 16014120
[TBL] [Abstract][Full Text] [Related]
10. The nuclear channel system in endometrial adenocarcinoma exposed to medroxyprogesterone acetate.
Horbelt DV; Delmore JE; Parmley TH; Roberts DK; Walker N
Hum Pathol; 1996 Jan; 27(1):9-14. PubMed ID: 8543319
[TBL] [Abstract][Full Text] [Related]
11. Sparing fertility in young patients with endometrial cancer.
Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
[TBL] [Abstract][Full Text] [Related]
13. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.
Kaku T; Yoshikawa H; Tsuda H; Sakamoto A; Fukunaga M; Kuwabara Y; Hataeg M; Kodama S; Kuzuya K; Sato S; Nishimura T; Hiura M; Nakano H; Iwasaka T; Miyazaki K; Kamura T
Cancer Lett; 2001 Jun; 167(1):39-48. PubMed ID: 11323097
[TBL] [Abstract][Full Text] [Related]
14. Successful pregnancy after conservative surgery for stage IA endometrial cancer in a young woman.
Yasuda M; Terai Y; Sekijima T; Sasaki H; Yamashita Y; Kanemura M; Ohmichi M
Fertil Steril; 2009 Mar; 91(3):936.e13-5. PubMed ID: 19062001
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate.
Nomura H; Sugiyama Y; Tanigawa T; Matoda M; Kanao H; Kondo E; Takeshima N
Arch Gynecol Obstet; 2016 Jan; 293(1):177-181. PubMed ID: 26209972
[TBL] [Abstract][Full Text] [Related]
16. Assisted reproductive technologies in conjunction with conservatively treated endometrial adenocarcinoma. A case report.
Ogawa S; Koike T; Shibahara H; Ohwada M; Suzuki M; Araki S; Sato I
Gynecol Obstet Invest; 2001; 51(3):214-6. PubMed ID: 11306913
[TBL] [Abstract][Full Text] [Related]
17. While women await surgery for type I endometrial cancer, depot medroxyprogesterone acetate reduces tumor glandular cellularity.
Fiascone S; Danilack VA; Kao MJ; Cohen M; Singh K; Kalife E; Luis C; Lokich E; DiSilvestro P; Robison K
Am J Obstet Gynecol; 2018 Oct; 219(4):381.e1-381.e10. PubMed ID: 30063901
[TBL] [Abstract][Full Text] [Related]
18. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
Rabban JT; Gilks CB; Malpica A; Matias-Guiu X; Mittal K; Mutter GL; Oliva E; Parkash V; Ronnett BM; Staats P; Stewart CJR; McCluggage WG
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S25-S39. PubMed ID: 30550482
[TBL] [Abstract][Full Text] [Related]
19. Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate.
Niwa K; Yokoyama Y; Tanaka T; Murase T; Morishita S; Itoh M; Itoh N; Shimokawa K; Tamaya T
Arch Gynecol Obstet; 1994; 255(2):91-4. PubMed ID: 8092891
[TBL] [Abstract][Full Text] [Related]
20. Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature.
Ohyagi-Hara C; Sawada K; Aki I; Mabuchi S; Kobayashi E; Ueda Y; Yoshino K; Fujita M; Tsutsui T; Kimura T
Arch Gynecol Obstet; 2015 Jan; 291(1):151-7. PubMed ID: 25118836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]